Saggar Rajeev reported option exercise involving 50,000 shares of Liquidia Corp at $3.73 for $187k on Aug 19, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Chief Medical Officer
Chief Medical Officer
Filed Aug 19, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$186,500Shares × reported price
Shares traded
50,000Common Stock
Price per share
$3.73Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
192,265Direct
Trade date
Aug 19, 2026Option exercise
Filed
Aug 19, 2026, 6:21 PM ET0-day reporting delay
Accession
0001104659-26-098862Code M · Transaction 11982
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 17, 2026Sell29,534$76.84−$2,269,380.75Trade 11981
Aug 19, 2026Sell50,000$74.06−$3,702,825Trade 11983
Aug 19, 2026Option exercise50,000$0.00$0Trade 11984
4 transaction rows in this filing. Joint filers share the same rows.

LQDA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
LQDA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +2.3%1w ago +4.6%1d ago −1.3%
Returns since7d −5.3%30d −11%90d180d1y

Footnotes in full

F1: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $76.76 to $77.13. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes (i) 10,416 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 21,184 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 44,862 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. F3: Represents the subsequent sale of the underlying shares from the exercise of stock options reported on this Form 4. F4: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $74.00 to $74.60. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5: The option vested over a four-year period with 25% vesting on July 18, 2023 and the remaining 75% vesting ratably on a monthly basis over three years thereafter and became fully vested on July 18, 2026.